×

Europe

f9a57bfe-51c7-11e9-8939-5623721d3707

Europe’s pragmatic approach to clinical evidence for legacy devices – or why the devil is always in the detail…

By Arthur Brandwood | 03.30.2019
Regulatory affairs demand attention to detail. So when the European Medical Devices Coordination Group released document MDCG 2019-3 - Interpretation of Article 54(2)b we regulatory geeks just knew we should...
TrainXstation

Halfway there? Will the MDR/IVDR train arrive on time – and what about Brexit?

By Luis Jimenez | 12.03.2018
As the implementation journey for the EU MDR/IVDR passes the halfway point, we provide an update to the current state of play and the impact on our industry. Many, if...

Search

Recent Posts

And so starts the MDR/Brexit fallout… First LRQA and now QS Zurich fall by the wayside

Jun 27, 2019

GMP Clearance Framework

Jun 27, 2019

Make Your Changes Now!

Jun 17, 2019

Brandwood Biomedical and Capital K Consulting to become Brandwood-CKC

Jun 4, 2019

Test or Evaluate? Biocompatibility and Orthopaedic materials

Jun 3, 2019

TGA will no longer send “friendly reminders” for Annual Reports.

Jun 2, 2019

Categories

Categories

Archives

Archives

Archives

Tags

3D 3D printing 510(k) 510(k) PMA adverse events Apple Watch Artificial Intelligence Australia Biocompatibility Biomechanics Brexit CE CE Certificates CFDA China clinical evidence de novo distribution Europe FDA Health Canada IVD IVDR MDR MDSAP mechanical properties medical device medical devices New Zealand Notified Bodies PMA PMDA postmarket post market premarket Quality Systems Reform regulatory Reimbursement SaMD Software standards Sterilisation TGA Webinar
Translate »